Veterinary Public Health and Epidemiology: Core Concepts and Applications

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Key Takeaways

• Veterinary public health leverages epidemiological principles to quantify disease burden using incidence (new cases over time) and prevalence (existing cases at a point/period), informing outbreak dynamics and resource allocation.
• Study designs like cross-sectional, cohort, and case-control studies are critical for identifying risk factors and causal associations, with experimental designs (e.g., randomized controlled trials) offering the highest evidence for intervention efficacy.
• Bias (selection, information) and confounding (e.g., age, breed, management) are inherent threats to the validity of observational epidemiological findings, necessitating rigorous analytical control.
• The One Health framework integrates human, animal, and environmental health, underscoring the interdependence of these sectors for effective zoonotic disease control (e.g., rabies, zoonotic influenza) and antimicrobial resistance management.
• Surveillance systems, encompassing passive, active, syndromic, and participatory approaches, are essential for continuous data collection and interpretation, with sensitivity and specificity of diagnostic tests and case definitions critically influencing data quality.
• Outbreak investigations follow a structured sequence from case confirmation to hypothesis testing and intervention, utilizing tools like epidemic curves and measures of association (relative risk, odds ratio) to guide control efforts.

Veterinary public health and epidemiology form the scientific bridge between animal health, human health, and ecosystem integrity. This article provides a foundational reference for veterinary researchers and graduate students who require a rigorous treatment of epidemiological principles as they apply to population-level animal health, zoonotic disease control, and the design of surveillance and intervention programs. It addresses the quantitative logic of disease measurement, the architecture of observational and experimental studies, and the practical translation of epidemiological findings into public health action across species and production systems.

The clinical veterinarian increasingly operates within a population context, whether managing a companion animal practice, a food animal herd, or a wildlife conservation program. Understanding how disease frequency is measured, how study designs generate evidence, and how bias and confounding distort inference is prerequisite to interpreting the literature and contributing to outbreak investigations. This article assumes familiarity with clinical terminology and focuses on the conceptual frameworks that underpin veterinary epidemiological practice, with attention to the One Health paradigm that links veterinary medicine to human public health and environmental management WHO One Health initiative.

At a Glance

Defining Veterinary Public Health and Its Epidemiological Basis

Veterinary public health encompasses all activities that veterinarians contribute to the protection and improvement of human health, including food safety, zoonotic disease control, environmental health, and biomedical research. Epidemiology supplies the methodological core of this discipline, providing the tools to quantify disease occurrence, identify risk factors, evaluate interventions, and monitor population health trends. The application of epidemiological principles extends beyond food animal medicine to exotic animal practice, where group health management and biosecurity planning depend on the same quantitative reasoning used in herd health programs epidemiology and herd health principles for exotic animal veterinarians.

The scope of veterinary public health has broadened considerably over recent decades. Traditional concerns with foodborne pathogens and livestock zoonoses now sit alongside emerging threats such as wildlife-origin diseases, antimicrobial resistance, and climate-sensitive infections. International frameworks such as the WHO One Health initiative and the CDC zoonotic disease resources emphasize that effective prevention requires coordinated action across human medicine, veterinary medicine, and environmental management CDC One Health and zoonotic disease resources. Veterinary epidemiologists contribute surveillance data, outbreak investigation capacity, and intervention evaluation that are indispensable to these cross-sectoral efforts.

Measures of Disease Frequency

Quantifying disease occurrence is the first analytical step in veterinary epidemiology. Three fundamental measures dominate: incidence, prevalence, and mortality rates. Each answers a different question and each has distinct limitations that influence interpretation.

Incidence

Incidence measures the rate at which new cases of disease appear in a population at risk during a specified time period. The numerator is the number of new cases, and the denominator is the sum of time at risk across all individuals in the population, often expressed as animal-time. Incidence density, expressed as cases per animal-year or per 100 animal-months, accommodates varying follow-up times and is the preferred measure in cohort studies and intervention trials. Cumulative incidence, by contrast, expresses new cases as a proportion of the population at risk at the start of the observation period, assuming complete follow-up.

Incidence is the measure of choice for studying disease etiology, evaluating preventive interventions, and detecting outbreaks. A rising incidence signals an emerging threat, whereas stable incidence with rising prevalence may indicate improved survival instead of increased transmission.

Prevalence

Prevalence describes the proportion of a population that has disease at a given point in time (point prevalence) or during a defined interval (period prevalence). It is a snapshot of disease burden and reflects the balance between disease incidence and disease duration. Conditions with long duration, such as chronic infections or degenerative diseases, tend to have high prevalence even when incidence is low. Conversely, acute diseases with rapid recovery or death may have low prevalence despite high incidence.

For surveillance purposes, prevalence surveys are often more practical than incidence studies because they require only a single cross-sectional sample. However, prevalence cannot distinguish between recent and long-standing cases, which limits its utility for causal inference.

Mortality and Case Fatality

Mortality rates quantify deaths in a population, while case fatality expresses the proportion of diagnosed cases that die from the disease. These measures are essential for assessing disease severity and for prioritizing interventions. In production animal medicine, mortality and culling rates directly affect economic viability and are routinely monitored as indicators of herd health.

Study Designs in Veterinary Epidemiology

The choice of study design determines what questions can be answered and what threats to validity must be managed. Veterinary epidemiology draws on the full range of observational and experimental designs, each with specific strengths and weaknesses.

Cross-Sectional Studies

Cross-sectional studies measure exposure and disease status simultaneously in a defined population at a single point in time. They are efficient for estimating prevalence, describing disease distribution, and generating hypotheses about risk factors. The principal limitation is temporal ambiguity: because exposure and outcome are measured concurrently, cross-sectional data cannot establish whether exposure preceded disease. This design is also biased toward prevalent instead of incident cases, which can distort associations for diseases with differential survival.

Cohort Studies

Cohort studies follow a defined population forward in time, measuring exposure at baseline and then tracking disease occurrence. The prospective cohort design provides the strongest observational evidence for causal associations because exposure is established before disease develops. Cohort studies are particularly valuable in veterinary medicine for evaluating production outcomes, vaccine effectiveness, and the natural history of disease. Their principal disadvantages are cost, duration, and loss to follow-up, which can introduce selection bias if attrition is related to both exposure and outcome.

Case-Control Studies

Case-control studies select individuals based on disease status and compare their historical exposure to that of disease-free controls. This design is efficient for rare diseases and for outbreaks where the population at risk is difficult to define. The case-control approach is retrospective by nature, which introduces recall bias and makes selection of appropriate controls the central methodological challenge. In veterinary outbreak investigations, case-control designs are frequently the only practical option because the outbreak is recognized after cases have already occurred.

Experimental Designs

Randomized controlled trials provide the highest grade of evidence for intervention efficacy. Random allocation of animals to treatment or control groups balances known and unknown confounders, provided the trial is adequately powered and allocation is concealed. Field trials in production settings, vaccine efficacy trials, and challenge studies in controlled facilities all fall within this category. Experimental designs are not always feasible or ethical, particularly for zoonotic diseases with severe consequences, and observational evidence must then carry the inferential burden.

Validity, Bias, and Confounding

The credibility of epidemiological findings rests on the control of systematic error. Selection bias arises when the study population is not representative of the target population, often through non-random participation or differential loss to follow-up. Information bias results from measurement error, including misclassification of exposure or disease status. Misclassification that is non-differential with respect to the other variable typically biases associations toward the null, whereas differential misclassification can bias in either direction.

Confounding occurs when a third variable is associated with both the exposure and the outcome and is not on the causal pathway between them. Age, sex, breed, and management system are common confounders in veterinary studies. Multivariable regression, stratification, and matching are standard tools for controlling confounding in analysis, but residual confounding from unmeasured variables remains a persistent threat to validity.

Participatory epidemiology offers a complementary approach to conventional quantitative methods, particularly in resource-limited settings where formal surveillance infrastructure is sparse. This methodology integrates local knowledge from animal caretakers with structured epidemiological inquiry, enabling disease detection and control program design in contexts where conventional data collection is impractical participatory epidemiology principles and utility. Its emphasis on triangulation and gender-sensitive engagement has expanded its application beyond infectious disease control to food security and One Health activities.

The One Health Framework in Veterinary Public Health

One Health is the unifying conceptual framework for contemporary veterinary public health. It recognizes that human health, animal health, and environmental health are interdependent and that effective disease control requires collaboration across sectors. The WHO One Health initiative articulates this vision at the international policy level, while the CDC provides operational guidance for zoonotic disease prioritization and cross-sectoral collaboration WHO One Health initiative.

The practical implications of One Health are substantial for veterinary epidemiologists. Rabies control exemplifies the framework in action: effective programs require coordinated vaccination of domestic animals, surveillance of wildlife reservoirs, public education, and post-exposure prophylaxis for humans. Recent analyzes of feline rabies in the Americas illustrate how gaps in surveillance and vaccination coverage for cats, combined with low public awareness and inconsistent reporting systems, undermine regional control efforts despite progress in dog-mediated transmission perceptions and barriers regarding rabies in cats in the Americas. This example demonstrates that epidemiological assessment must extend beyond pathogen biology to include the social, operational, and policy dimensions that determine program success.

Antimicrobial resistance similarly demands a One Health approach. The overuse of antimicrobials in both human and animal medicine drives resistance selection, and the resulting resistant organizms move across species and environmental compartments. Whole genome sequencing is emerging as a powerful tool for tracing transmission pathways and understanding resistance dynamics, although challenges in interpretation and cost remain technology for prevention of antimicrobial resistance and healthcare-associated infections. Veterinary epidemiologists contribute resistance surveillance data, risk factor analyzes, and stewardship intervention evaluations that are essential to this global effort.

Surveillance Systems and Data Sources in Veterinary Public Health

Surveillance is the continuous, systematic collection, analysis, and interpretation of health data essential to planning, implementation, and evaluation of public health practice. Veterinary public health surveillance operates across multiple tiers: passive reporting from diagnostic laboratories and practitioners, active surveillance programs targeting specific pathogens, syndromic surveillance using clinical signals, and participatory approaches that engage animal caretakers directly.

Passive surveillance remains the backbone of most national systems but suffers from underreporting, particularly for conditions that do not present with distinctive clinical signs or that lack diagnostic confirmation. Active surveillance, by contrast, applies standardized sampling protocols to detect subclinical infection or measure pathogen prevalence in defined populations. The choice between these approaches depends on the disease in question, the resources available, and the consequences of missing cases.

Participatory epidemiology offers a complementary pathway, particularly in resource-limited settings where formal diagnostic infrastructure is sparse. This approach combines practitioner communication skills with participatory methods to involve animal caretakers in disease identification and assessment, embracing their knowledge and experience in the design and evaluation of control programs. Participatory epidemiology principles and utility have been adapted beyond infectious disease control into food and nutrition security programs, wildlife surveillance, and mixed-methods research across diverse socio-economic settings. Data triangulation, including conventional confirmatory testing, remains essential to validate participatory findings.

Surveillance Design Considerations

Surveillance data quality depends on case definitions that are consistent across reporting sites and over time. A confirmed case requires laboratory verification, while a suspected case rests on clinical or epidemiological criteria. The sensitivity and specificity of the case definition directly affect the interpretation of trends, and changes in diagnostic capacity can produce apparent changes in disease incidence that reflect testing practices instead of true epidemiological shifts.

Outbreak Investigation and Field Epidemiology

The outbreak investigation follows a structured sequence: confirm the diagnosis, establish a case definition, identify and count cases, describe the outbreak by time, place, and person or animal, generate hypotheses about the source and mode of transmission, test those hypotheses analytically, and implement control measures. This sequence applies across species and production systems, though the practical details differ.

In food animal populations, the investigation typically begins with a producer or herd veterinarian reporting increased morbidity or mortality. The case definition must accommodate the production context, including age cohorts, pen assignments, and management changes. In companion animal practice, outbreaks more often involve multi-pet households, boarding facilities, or veterinary hospitals, where transmission dynamics differ substantially from herd settings. Exotic animal veterinarians occupy a distinctive position, as they are often the first to encounter emerging or exotic disease threats and can identify antimicrobial resistance patterns before they reach food animal or human populations. Epidemiological principles for exotic animal practice extend the traditional herd health framework to collections, shelters, and individual patients managed as populations.

The epidemic curve remains the central descriptive tool. A point-source outbreak produces a sharp peak followed by a rapid decline, propagated spread produces successive waves with increasing amplitude, continuous exposure produces a plateau. The shape of the curve, combined with the incubation period, allows estimation of the exposure window and guides the search for a common source.

Analytical studies during an outbreak typically begin with a retrospective cohort design when the population at risk is well defined, such as animals on a single farm. A case-control design becomes necessary when the population at risk cannot be enumerated, as in a community-wide outbreak of zoonotic disease. The measures of association, relative risk for cohort studies and odds ratio for case-control studies, quantify the strength of the exposure-disease relationship and support decisions about intervention priorities.

Risk Assessment and Communication

Risk assessment in veterinary public health follows the framework of hazard identification, hazard characterization, exposure assessment, and risk characterization. This structure applies to chemical residues, biological agents, and antimicrobial resistance determinants. The output is a statement about the probability and magnitude of adverse effects under specified conditions of exposure.

The assessment must specify the population at risk, the route of exposure, and the dose-response relationship. For zoonotic pathogens, the relevant exposure pathways include direct contact with infected animals, consumption of contaminated food products, environmental contamination, and arthropod vectors. Each pathway requires separate exposure assessment, and the relative contribution of each pathway determines where intervention resources should be directed.

Risk communication differs from risk assessment. Effective communication acknowledges uncertainty, presents probabilities in accessible formats, and addresses the concerns of the affected community. The One Health perspective requires that risk communication span human and animal health sectors, veterinary and medical practitioners, and public health authorities. WHO One Health guidance emphasizes that zoonotic disease control and antimicrobial resistance management require coordinated action across these sectors, and CDC zoonotic disease resources provide frameworks for cross-sector collaboration and disease prioritization.

Antimicrobial Resistance Surveillance

Antimicrobial resistance surveillance in veterinary public health serves two distinct purposes: monitoring resistance trends in animal pathogens to guide therapeutic choices, and detecting resistance determinants that may transfer to human pathogens. These purposes require different sampling strategies and different interpretive criteria.

Clinical isolates from diagnostic submissions reflect the population of diseased animals and are biased toward cases that fail initial therapy. Surveillance isolates from healthy animals, collected through active sampling programs, provide a less biased picture of the resistance reservoir. Whole genome sequencing offers the capacity to identify resistance genes, mobile genetic elements, and clonal relationships between animal and human isolates, though interpretation challenges and costs remain significant. Technology for prevention of antimicrobial resistance includes microbiome research that may expand understanding of how antimicrobial use in animals selects for resistance and whether interventions such as probiotics can reduce that selection pressure.

The veterinary curriculum has limited contact hours devoted to antimicrobial resistance, with instructors reporting a median of 3 to 5 hours in the core curriculum. Survey of antimicrobial resistance instruction identified that most teaching occurs within food animal medicine instead of as a distinct topic, and instructors prioritized subtopics related to clinical decision-making and stewardship. This educational foundation shapes how practitioners approach resistance surveillance and interpret susceptibility data in practice.

Program Evaluation and the Veterinary Public Health Workforce

Evaluation of veterinary public health programs requires explicit objectives, measurable indicators, and a defined time frame. Process indicators measure whether activities were implemented as planned, such as vaccination coverage achieved or number of samples collected. Outcome indicators measure whether the program changed the target condition, such as reduced disease incidence or decreased prevalence of infection. Impact indicators assess the ultimate public health benefit, such as reduced human cases of zoonotic disease.

The workforce that conducts this work requires training that extends beyond clinical medicine. A review of educational opportunities in US veterinary schools found that students receive a median of 60 hours of public health, epidemiology, and preventive medicine in required stand-alone courses, with contact time ranging from 30 to 150 hours across institutions. Veterinary public health workforce training identified advanced training opportunities at 79% of schools, but the variability in required contact hours suggests substantial differences in foundational preparation. The future of veterinary public health depends on educational pathways that encourage students to pursue public service careers, including electives, rotations, and postgraduate programs.

Program evaluation must also address the barriers that limit program effectiveness. In rabies control, for example, cats are increasingly recognized as incidental hosts and potential transmission bridges between wildlife reservoirs and humans, yet most national programs exclude them from systematic surveillance and vaccination. Perceptions and barriers regarding rabies in cats identified low public awareness, inconsistent reporting systems, and the absence of feline-specific policies as major barriers, with intervention priorities emphasizing public education, improved feline vaccination coverage, and expanded sterilization programs to reduce population turnover. These findings illustrate how program evaluation must consider the social and operational context, also the biological characteriztics of the pathogen.

Recognized Complications and Failure Modes in Veterinary Public Health Practice

Veterinary public health interventions fail through predictable pathways. Surveillance systems collapse when reporting becomes passive and dependent on clinician initiative without feedback loops. Vaccination campaigns underperform when target populations are excluded from program design, a pattern documented for feline rabies control in the Americas where national programs frequently omit cats from systematic surveillance and vaccination despite their role as transmission bridges between wildlife and humans (Perceptions and Barriers Regarding Rabies in Cats in the Americas). Outbreak responses stall when field data are not triangulated with laboratory confirmation, allowing misclassification of index cases and delayed identification of the true exposure source.

Early detection of these failures requires embedded process indicators instead of reliance on outcome measures alone. For surveillance, monitor reporting completeness, timeliness of case confirmation, and the proportion of submissions yielding a definitive diagnosis. For intervention programs, track coverage gaps by species, geographic region, and production system. A decline in specimen submission rates often precedes a decline in detected cases, and distinguishing these requires separate monitoring streams.

Common Errors by Less Experienced Practitioners

Students and early-career veterinarians frequently conflate prevalence with incidence when interpreting surveillance reports, leading to incorrect inferences about transmission dynamics. A high prevalence in a chronic disease may reflect excellent survival instead of high transmission. The corrective action is to require explicit specification of the time window and the population at risk before interpreting any measure of disease frequency.

A second recurring error is the over-interpretation of cross-sectional data for causal inference. Associations identified in a single time point cannot establish temporal sequence, and practitioners should resist recommending interventions based on prevalence associations alone. The corrective framework is to demand consistency across study designs and to weight evidence from cohort or experimental studies more heavily when causal claims are made.

A third error involves the application of food animal epidemiological methods to exotic animal or companion animal populations without adjustment. Group health programs for exotic collections require different sampling strategies, different case definitions, and different biosecurity assumptions than production animal herds (Application of Epidemiology and Principles of Herd/Flock Health for the Exotic Animal Veterinarian). Practitioners should explicitly identify which assumptions of the production animal framework do not transfer before adapting protocols.

Limitations of Current Evidence and Areas of Expert Disagreement

The evidence base for veterinary public health interventions is uneven. Participatory epidemiology has demonstrated utility in resource-limited settings for disease control and early warning, but its integration with conventional confirmatory testing and its performance in high-income contexts remain areas of active development instead of settled practice (Participatory Epidemiology: Principles, Practice, Utility, and Lessons Learnt). Expert opinion differs on the appropriate balance between participatory methods and traditional surveillance, particularly regarding the weight given to local knowledge versus laboratory-generated data.

Whole genome sequencing is widely endorsed as a powerful tool for transmission investigation, but interpretation challenges and cost constraints limit routine deployment in many settings (Technology for the prevention of antimicrobial resistance and healthcare-associated infections). Experts disagree on the threshold at which genomic data should replace or supplement conventional typing methods for routine surveillance, and on how to handle the bioinformatic capacity gap in smaller diagnostic laboratories.

The veterinary public health workforce itself presents an evidence gap. Educational opportunities vary substantially across institutions, with required contact hours in public health, epidemiology, and preventive medicine ranging from 30 to 150 hours across US veterinary schools (Training the veterinary public health workforce). Whether this variation translates into measurable differences in workforce competency has not been established, and expert opinion differs on whether the solution is curricular standardization or expanded postgraduate pathways.

Escalation, Referral, and Regulatory Reporting

Veterinary public health problems escalate through defined pathways. When a cluster of cases exceeds expected background incidence, the first step is notification of the relevant animal health authority. The World Organization for Animal Health terrestrial code provides the international framework for notification obligations and trade-related disease control (WOAH Terrestrial Animal Health Code). Practitioners should know which diseases are notifiable in their jurisdiction and the time limits for reporting, as these vary by country and by species.

Referral to specialist services is indicated when local diagnostic capacity is exceeded. Molecular typing, antimicrobial susceptibility testing for emerging resistance patterns, and wildlife disease investigation typically require reference laboratory involvement. Consultation with an epidemiologist is warranted when study design questions arise, when surveillance data require complex statistical analysis, or when an outbreak investigation exceeds the capacity of the practice to manage data collection and analysis.

Regulatory reporting is mandatory for certain zoonoses and for antimicrobial resistance findings with public health implications. The threshold for reporting should be conservative: when in doubt, consult the relevant authority before deciding not to report. The One Health framework explicitly requires cross-sectoral communication, and the World Health Organization and the Centers for Disease Control and Prevention both maintain guidance on zoonotic disease prioritization and cross-sector collaboration (WHO One Health Initiative, CDC One Health and Zoonotic Disease Resources). Failure to report a notifiable disease is a professional and legal error that cannot be corrected retrospectively.

Frequently Asked Questions

How Do I Prioritize Surveillance Activities When Funding and Staffing Are Limited?

Prioritize based on the intersection of zoonotic potential, economic impact, and feasibility of intervention. Diseases with documented transmission bridges between wildlife, domestic animals, and humans warrant the highest attention, particularly when existing programs already address the primary reservoir. For example, rabies programs that concentrate on dog-mediated transmission may leave feline populations as an underrecognised pathway, a gap identified by professionals across the Americas in a survey of rabies perceptions and barriers. Use passive surveillance for common conditions and reserve active surveillance for high-consequence pathogens. Syndromic surveillance using existing clinical records can substitute for laboratory-based systems when diagnostic budgets are constrained. Align priorities with WOAH terrestrial animal health standards to maintain trade compatibility while addressing local needs.

What Is the Minimum Data Set Needed to Investigate a Disease Cluster in a Herd or Population?

Collect case definitions, animal identification, location, onset dates, and relevant exposure histories. For production animals, include group or pen assignment, movement records, and feed or water source information. For companion animal populations, capture household composition and contact with wildlife or other domestic species. Record diagnostic test results with laboratory accession numbers. A denominator is essential: you cannot interpret cluster size without knowing the population at risk. When full data are unavailable, begin with a line listing and calculate attack rates by group. Participatory epidemiology methods can elicit valuable information from animal caretakers when written records are sparse, as described in the principles and practice of participatory epidemiology. Store records in a format that permits later linkage to laboratory and treatment data.

How Should I Adapt Epidemiological Methods for Exotic Animal Practice?

Apply the same measures of disease frequency and study designs used in production animal medicine, but adjust the unit of interest. For a zoo collection, the group may be a taxonomic order or a housing zone instead of a herd. For individual exotic pets, the practice population serves as the denominator for prevalence estimates. Outbreak investigation follows the same sequence of case definition, descriptive epidemiology, and hypothesis testing. Exotic animal veterinarians occupy a valuable position for detecting emerging threats because their patients often originate from wildlife trade or importation, as noted in epidemiology and herd health for the exotic animal veterinarian. Maintain detailed records of source origins, quarantine periods, and cohabitation patterns. When population sizes are small, interpret incidence and prevalence with wider confidence intervals and avoid overinterpreting apparent trends.

What Do I Do When Diagnostic Testing Is Unavailable or Delayed?

Proceed with a working case definition based on clinical signs and epidemiological context. Treat suspect cases according to the most likely differential while collecting samples for later confirmatory testing. Document the basis for your presumptive diagnosis so that retrospective classification remains possible. In outbreak settings, use the epidemiological curve to guide decisions about source identification and control measures before laboratory confirmation arrives. Triangulate multiple information sources, including clinical observations, caretaker reports, and available test results, to strengthen conclusions. Participatory epidemiology approaches emphasize this triangulation and can be applied even in well-resourced settings when rapid results are needed, as outlined in the review of participatory epidemiology methods. Clearly communicate to stakeholders that control decisions may need revision once laboratory results become available.

How Do I Explain Population-Level Findings to an Owner or Producer Who Focuses on Individual Animals?

Frame the message around the health of the group and the individual within it. Explain that treating one animal without addressing the population context risks recurrence. Use absolute numbers instead of percentages when the group is small. Show the owner a simple epidemic curve or attack rate calculation to make the pattern visible. Emphasize that interventions such as vaccination, biosecurity, or culling protect the animals they care about, also an abstract population. Acknowledge the emotional and financial costs of group-level decisions. For production clients, connect disease metrics to productivity outcomes they already track. For companion animal owners, relate population health to the risk of zoonotic transmission to household members. The CDC One Health resources provide framing language that connects animal, human, and environmental health in terms accessible to lay audiences.

When Should I Escalate a Finding to Regulatory Authorities?

Escalate when a disease is reportable by law, when a zoonotic pathogen shows unusual transmission patterns, or when an outbreak exceeds the capacity of local control measures. Report suspected notifiable diseases immediately instead of waiting for laboratory confirmation. If you are uncertain whether a condition is reportable, contact the relevant authority for guidance before acting. Document your clinical findings, sample submissions, and communication attempts. In multi-jurisdiction situations, such as animals crossing state or national borders, follow the requirements of both the origin and destination authorities. International movement of animals and animal products is governed by standards that define notification obligations, and veterinarians should be familiar with these international animal health standards. When regulatory action may have economic consequences for a client, explain the legal basis for reporting and the expected next steps.

Related Clinical & Scientific Guides

• Wildlife Disease Surveillance: Designing and Implementing a One Health Program
• Biosecurity Risk Assessment for Livestock Operations: A Practical Framework
• Rabies Post-Exposure Prophylaxis in Veterinary Personnel

References and Further Reading

• Perceptions and Barriers Regarding Rabies in Cats in the Americas: An Approach From the One Health Perspective.. 2026.
• Participatory Epidemiology: Principles, Practice, Utility, and Lessons Learnt.. 2020.
• Training the veterinary public health workforce: a review of educational opportunities in US veterinary schools.. 2004.
• Survey of instructors teaching about antimicrobial resistance in the veterinary professional curriculum in the United States.. 2013.
• Technology for the prevention of antimicrobial resistance and healthcare-associated infections, 2017 Geneva IPC-Think Tank (Part 2).. 2019.
• Application of Epidemiology and Principles of Herd/Flock Health for the Exotic Animal Veterinarian.. 2021.
• WHO One Health Initiative. WHO.
• CDC One Health and Zoonotic Disease Resources. CDC.
• MSD Veterinary Manual, Professional Edition. MSD Veterinary Manual.

Related Articles

• Veterinary Public Health and Food Safety: A Systems Approach
• Veterinary Public Health Careers: Roles in Government, Academia, and Industry
• Veterinary Public Health and Climate Change: Impact on Zoonoses
• Veterinary Public Health and Wildlife Trade: Risk Assessment
• Zoonotic Parasites in Wildlife: Diagnostic Challenges and Public Health Implications

This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.